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Background/aim: Body weight-supported treadmill training (BWSTT) might have greater effects than conventional treadmill training
(TT) in neurological diseases such as Parkinson’s disease (PD). The aim of this study was to evaluate the effects of different percentages
of BWSTT on gait, balance, quality of life, and fatigue in PD.
Materials and methods: Thirty-five patients with moderate to advanced PD were randomized into three BWSTT groups according to
the supported percentage of body weight: 0% BWSTT (control group; unsupported TT), 10% BWSTT, or 20% BWSTT. Five patients
were excluded due to early discharge and 30 patients completed BWSTT sessions lasting 30 min, 5 days a week, for 6 weeks during their
inpatient rehabilitation stay. The primary outcome was 6-min walk distance (6MWD). Secondary outcomes were Unified Parkinson’s
Disease Rating Scale (UPDRS), Berg Balance Scale (BBS), Nottingham Health Profile (NHP), Fatigue Impact Scale, and Fatigue Severity
Scale scores. Measurements were performed before and after the training.
Results: The unsupported TT group demonstrated no significant improvement in the outcome measures after a 6-week training except
for BBS and NHP emotional subscores. Moreover, the NHP pain subscore increased in the unsupported TT group after training. The
10% and 20% supported BWSTT groups demonstrated significant improvements in 6MWD (P = 0.004 and P < 0.001, respectively),
UPDRS - motor score (P = 0.012 and P = 0.005, respectively), NHP pain subscore (P = 0.003 and P = 0.002, respectively), and fatigue (P
= 0.005 for both) after training. The 20% BWSTT provided the highest improvement in balance among the three groups (P < 0.001) and
greater relief of fatigue than 10% BWSTT (P = 0.002).
Conclusion: Six weeks of BWSTT improved walking distance and balance ability, relieved fatigue, and additionally reduced pain in
patients with moderate to advanced PD.
Keywords: Parkinson’s disease, gait, balance, treadmill training, fatigue

1. Introduction
Parkinson’s disease (PD) is a progressive and degenerative
disorder characterized by an inadequate production
of dopamine due to pathology in the substantia nigra.
Rigidity, bradykinesia, and postural instability are
the cardinal features that lead to gait impairment and
functional limitations [1]. Gait and balance impairments
are important determinants of disability and quality of
life in PD [2]. Overall, fatigue is one of the most common
and disabling nonmotor symptoms and can be seen at all
stages of the disease [3].

Aerobic training with treadmill training (TT) is
effective in improving the gait, balance, and quality of
life and relieving fatigue in subjects with PD [4,5]. Body
weight-supported treadmill training (BWSTT) allows
safe walking practice by supporting a portion of the body
weight mechanically and stimulates activity-dependent
neural plasticity [6]. Furthermore, physical performance
and aerobic activities can be performed at higher
intensities when the body weight is partially supported
during walking compared to conventional TT [7]. This is
especially beneficial in the rehabilitation of neurologically
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impaired subjects, such as PD patients. Ganesan et
al. showed that BWSTT had greater improvements of
disability and gait parameters than ground walk training
in PD. However, since the control group was not trained
on a treadmill wearing a harness without partial body
weight support, study participants were not blinded to the
study. They also included only 20% supported BWSTT
in the intervention group. Hence, it is not possible to
interpret the effect of BWSTT over TT or the effects of
different amounts of body weight support on clinical and
gait performance. In that study, the effects of BWSTT on
balance, quality of life, and fatigue were not investigated as
outcome measures, either [8].
The primary hypothesis of this study is that 20%
supported BWSTT will lead to greater improvements in gait
performance than 10% supported BWSTT or unsupported
TT in PD. The second hypothesis is that BWSTT will
provide significant improvements in balance, disability,
quality of life, and fatigue. To test these hypotheses, it is
aimed to assess the effects of 20%, 10%, and 0% BWSTT
on gait as well as balance, quality of life, and fatigue in
subjects with PD.
2. Materials and methods
This randomized controlled double-blind study was
approved by the Ethics Committee of the Gazi University
Medical Faculty (No: 2010-171) and registered in the
Clinical Trials database (NCT03799887). Participants
were fully informed about the procedures and written
consent was obtained.
2.1. Participants
Participants who were diagnosed with idiopathic PD
according to the UK Brain Bank criteria were recruited
from the Movement Disorders Outpatient Clinic of the
Gazi University Neurology Department. Patients with
moderate to advanced disease (Hoehn and Yahr stage 2–4)
with stable doses of dopaminomimetics for at least 4 weeks
and who were able to walk with or without assistive devices
were included. Exclusion criteria were cardiovascular,
inflammatory, musculoskeletal, or cognitive problems
(Mini Mental Status Examination (MMSE) score of less
than 26) that could prevent their participation in the
training program. Participants were hospitalized in the
inpatient rehabilitation unit of the Gazi University Physical
Medicine and Rehabilitation Department.
2.2. Measurements
Demographic features, clinical parameters, Hoehn and
Yahr Stages, MMSE scores, and medications were recorded.
Hoehn and Yahr staging measures the severity of PD in
stages 0 through 5. Higher stages mean more advanced
disease. Stage 0 means no findings of the disease and stage
5 means the most advanced disease in which the patient is
wheelchair-bound or bedridden unless aided. The Turkish
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version of the MMSE was used to assess cognitive status
[9].
The following measurements were performed before
and after the training program by a blinded physiatrist and
neurologist at the same time of the day. Medications for PD
were kept at stable doses during the study and the outcome
measurements and interventions were performed during
“on” periods.
2.3. Primary outcome measurement
The 6-min walk test (6MWT) is a submaximal exercise test
usually corresponding to 80% of a subject’s maximum heart
rate and is used to assess functional capacity and treatment
response [10,11]. The patients were asked to walk as long
as possible for 6 min on 30 m of marked and flat ground
at a self-selected speed. Standard instructions were used
and ambulatory devices were permitted. Distance walked
in 6 min (6MWD) was recorded. Healthy people have an
average walking distance of 500–700 m [12].
2.4. Secondary outcome measurements
The Berg Balance Scale (BBS) contains 14 items. Each item
is scored from 0 (total inability to perform the activity) to
4 points (ability to perform the activity independently).
Higher scores indicate a better balance ability [13]. The
Turkish version was used [14].
The Unified Parkinson’s Disease Rating Scale (UPDRS)
is used to assess disability in PD. It consists of four main
parts (totally 183 points): mentation, behavior, and mood
(UPDRS I: 16 points); activities of daily living (UPDRS II:
52 points); motor examination (UPDRS III: 92 points);
and treatment complications (UPDRS IV: 23 points).
Higher scores indicate worse clinical disease. UPDRS I, II,
and III were used in this study. UPDRS III in particular
helps to monitor treatment and measure the effectiveness
of treatment. Speech, facial expression, tremor at rest,
action tremor of hands, rigidity, finger taps, hand grips,
pronation-supination movements of hands, leg agility,
rising from chair, posture, gait, postural stability, and body
bradykinesia were evaluated. For this section each item
is scored from 0 (normal) to 4 (unable to do it). Higher
scores indicate worse clinical disease. The UPDRS was
administered by a neurologist specialized in movement
disorders.
The Turkish version of Nottingham Health Profile
(NHP) was used to assess health-related quality of life [15].
It contains 38 items that address pain, physical mobility,
emotional reactions, energy, social isolation, and sleep
dimensions. Higher scores indicate worse quality of life.
The Fatigue Impact Scale (FIS) assesses the cognitive,
physical, and social effects of fatigue during the last week
in a 40-item questionnaire (0 = no problem, 4 = maximum
problem). The total score ranges from 0 to 160. Higher
scores reflect a higher degree of fatigue [16]. The validity
and reliability of the Turkish version was demonstrated [17].
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The Fatigue Severity Scale (FSS) assesses the severity
of fatigue during the last week in a 9-item questionnaire (1
= strongly disagree, 7 = strongly agree). Total score ranges
from 9 to 63, with higher scores representing greater
fatigue [18]. The validity and reliability of the Turkish
version was shown [19].
2.5. Interventions
All participants received 30 min of conventional
rehabilitation including range of motion, stretching,
strengthening, and balance exercises followed by 30 min
of BWSTT performed on a BWSTT unit (Biodex Medical
Unweighing System, Model 945-480 (serial no: 04111171),
Shirley, NY, USA), 5 days a week, for 6 weeks. Each BWSTT
session consisted of a 5-min warm-up and cool-down
period and was intended to include 25 min of submaximal
aerobic exercise. Exercise intensity was adjusted according
to 6MWD. Heart rate achieved at the end of the 6MWT
was regarded as the target BWSTT heart rate [20]. This
exercise intensity was submaximal and the heart rate and
blood pressure were measured during training sessions,
and treadmill speed was tailored to reach the target HR.
Maintenance of the heart rate during training sessions was
important both for providing standard exercise intensity
for each patient and for maintaining cardiovascular safety
to prevent unwanted cardiac events, especially in patients
with cardiovascular disease and hypertension. Feedback
related to speed of gait, symmetry of step length, or
posture was given to the patients by the physiotherapists.
Amount of body weight support applied during BWSTT
was set according to the randomization.
2.5.1. Randomization
Participants were randomized by a computer program
into three groups according to the supported percentage
of body weight: 0% BWSTT (control group; unsupported
TT), 10% BWSTT, or 20% BWSTT after age, sex, and stage
of disease matched blocks were constructed. A second
physiatrist who was not involved in the assessment of
study outcome measures performed the randomization
and prescribed the individualized rehabilitation program
accordingly. This prescribed rehabilitation program was
administered by two physiotherapists who were told not to
mention the treatment allocation to the participants and
the blinded physiatrist and neurologist. Before discharge
from the hospital, all outcome assessments were repeated
by the same blinded physiatrist and neurologist.
The power of this study was calculated as 0.84 with
10 patients in each group, with noncentrality parameter
of 11.98 and type-I error rate of 0.05. The schematic flow
diagram of the study is presented in the Figure. Thirty-five
patients with idiopathic PD were included in the study.
Five patients were discharged early and lost to follow-up,
leaving 10 patients in each group.

2.6. Statistical analysis
Demographic data and clinical features are presented as
mean and standard deviation (SD). A design of 3 (groups)
× 2 (times – baseline and 6th week) was used. Baseline
measurements among groups were compared using oneway analysis of variance (ANOVA). The paired samples
t-test was used to assess the differences between pre- and
posttraining within each group. Statistically different
parameters were analyzed by Mann–Whitney U test to
verify the group the difference originated from. A Scheffe
multiple comparison test was used after ANOVA. Effect
size (ES) was used to compare differences in the evaluation
of exercise training among groups. ES was used to evaluate
the amount of change in outcome measurements in each
intervention group. ES was identified as 0.2–0.5 = small,
0.5–0.8 = moderate, and >0.8 = large. Statistical analysis
was performed with SPSS 21.0 for Windows (IBM Corp.,
Armonk, NY, USA) and P ≤ 0.05 was considered a
statistically significant difference.
3. Results
Age, sex, height, weight, body mass index, duration and
severity of PD, levodopa equivalent doses, and MMSE
scores did not differ (all P > 0.05) among the three groups
(Table 1).
Thirty participants completed the 6-week training
program, which was well tolerated, and no adverse events
were observed except for knee pain. Adherence to the
training program was similar among the groups (Table 2).
The unsupported TT group demonstrated no
significant improvement in the outcome measures after
training except for BBS and NHP emotional subscores
(Table 3).
After training, the 6MWD improved significantly in
the 10% and 20% supported groups. The 20% supported
group achieved the greatest 6MWD at the 6th week among
the three groups; however, this did not reach statistical
significance.
All groups showed significant increases in BBS after
training compared to baseline (P = 0.008, P = 0.011, and P
= 0.005, respectively). The difference in the 6th week BBS
scores among groups was significant, originating from the
20% supported group (P < 0.001).
After training, the UPDRS III scores were significantly
decreased in the 10% and 20% supported groups (P = 0.012
and P = 0.005, respectively). The 20% supported group
demonstrated the greatest amount of reduction in UPDRS
III among the three groups, which was not statistically
significant.
Pain, energy, and physical subscores of NHP were
significantly different among groups. Pain subscores at
the 6th week increased significantly in the unsupported
TT group (P = 0.019), whereas they decreased in the 10%
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Figure. The schematic flow diagram of the study design. PD: Parkinson’s disease, BWSTT: body weight-supported treadmill training,
CRP: conventional rehabilitation program, 6MWT: 6-min walk test, BBS: Berg Balance Scale, UPDRS: Unified Parkinson’s Disease
Rating Scale, NHP: Nottingham Health Profile, FIS: Fatigue Impact Scale, FSS: Fatigue Severity Scale.

and 20% supported groups (P = 0.003 and P = 0.002,
respectively) compared to baseline. There were significant
improvements in the 10% and 20% supported groups in
energy (P = 0.004 and P < 0.001, respectively) and physical
subscores (P = 0.003 and P = 0.002, respectively).
After training, the 10% and 20% supported groups
showed significant improvements in both FIS and FSS
scores (P = 0.005, both groups for each score). The 20%
supported group showed the greatest amount of reduction
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in FIS and FSS scores after training but only the difference
in FSS reached statistical significance (P = 0.002).
4. Discussion
The findings of this study supported our primary hypothesis
that BWSTT would improve gait performance in subjects
with PD. Both the 10% and 20% supported BWSTT groups
demonstrated improvements in walking distance, whereas
unsupported TT did not show significant improvement.
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Table 1. Demographic and clinical features of the groups.
0% unsupported
(n = 10)

10% supported
(n = 10)

20% supported
(n = 10)

P

Age, years, mean (SD)

69.7 (8.0)

72.2 (7.9)

68.6 (8.2)

0.596

Women, n (%)

7 (70%)

6 (60%)

6 (60%)

0.886

Height, cm, mean (SD)

164.1 (7.7)

162.6 (9.6)

162.2 (5.4)

0.847

Weight, kg, mean (SD)

73.6 (13.7)

77.1 (9.7)

72.2 (11.3)

0.632

BMI, kg/m², mean (SD)

27.62 (6.74)

29.17 (3.04)

27.58 (4.56)

0.724

Duration of disease, years, mean (SD)

5.6 (5.3)

9.8 (9.0)

7.6 (6.4)

0.347

Stage 2, n (%)

5 (50%)

3 (30%)

4 (40%)

Stage 3, n (%)

4 (40%)

6 (60%)

5 (50%)

Stage 4, n (%)

1 (10%)

1(10%)

1(10%)

Levodopa equivalent dose, mg, mean (SD)

698.1 (207.2)

696.5 (195.5)

884.0 (253.6)

0.110

MMSE score, mean (SD)

28.4 (1.8)

28.8 (1.6)

28.3 (1.8)

0.796

7 (70%)

5 (50%)

3 (30%)

0.218

2 (20%)

4 (40%)

2 (20%)

0.534

3 (30%)

1 (10%)

2 (20%)

0.563

0 (0%)

1 (10%)

3 (30%)

0.142

5 (50%)

5 (50%)

6 (60%)

0.886

4 (40%)

4 (40%)

2(20%)

0.576

Hoehn and Yahr

0.139

Comorbidities, n (%)
Hypertension
Diabetes mellitus
Cardiovascular disease
Anemia
Osteoarthritis
Usage of ambulatory assistive device, n (%)

BMI: Body mass index, MMSE: Mini-Mental State Examination, SD: standard deviation.
Table 2. Features of completed training sessions in different body weight-supported treadmill training groups.
0% unsupported,
mean (SD)

10% supported,
mean (SD)

20% supported,
mean (SD)

P

Number of sessions

25.3 (5.1)

21.9 (6.8)

24.2 (8.2)

0.537

Duration of sessions, min

73.5 (13.1)

61.0 (3.2)

69.5 (9.8)

0.223

Total duration of aerobic exercise, min

25.5 (5.9)

22.5 (5.4)

23.5 (5.2)

0.481

Duration of submaximal aerobic exercise, min

12.7 (2.9)

11.2 (2.7)

11.7 (2.6)

0.481

SD: Standard deviation, min: minutes.

Regarding the second hypothesis, balance improvement
was greatest in the 20% supported BWSTT group and
UPDRS motor scores improved in both supported
BWSTT groups, but did not improve in unsupported TT.
The 6-week BWSTT also improved the quality of life and
relieved fatigue compared with unsupported TT in PD.
Improvements observed in gait and UPDRS motor
scores after BWSTT are consistent with previous PD
studies [7,8,21–23]. In the literature, 20% is the most
widely used percentage of unweighing in BWSTT studies,
as individuals with PD reported that 20% body weight
support was the most comfortable among 0%, 10%, 20%,

and 30% unweighted supports [23]. Researchers used
either 20% [7,8] or a combination of 20% and 10% [22–
24] unweighing in their BWSTT protocols and compared
BWSTT to overground gait training [7,8,24] or traditional
rehabilitation programs [22,23]. None of these studies
performed blinding of the participants. Our study is
unique in comparing two different percentages of BWSTT
(10% and 20%) to an unsupported TT group and providing
blindness of the study participants.
On the other hand, a recent study did not prove a
superior effect of BWSTT over conventional TT and
showed that they both improved gait, balance, and
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Table 3. Walking distance, balance, UPDRS, NHP, and fatigue scores before and after training.
0% unsupported
Mean (SD)

10% supported
Mean (SD)

20% supported
Mean (SD)

P1
P2

Effect
size (d)

6MWD, m
Basal
6th week

206.6 (111.4)
222.5 (108.8)

188.6 (106.4)
272.7 (124.3)*

164 (59.8)
374.5 (130.9)*

0.611
0.059

–0.49

BBS
Basal
6th week

35.8 (7.3)
40.9 (7.1)*

36.5 (5.0)
45.5 (7.5)*

32.2 (7.5)
51.7 (2.6)*

0.321
0.004

–1.84

1.9 (2.6)
1.7 (2.1)

0.9 (1.0)
0.9 (1.1)

1.6 (1.8)
1.6 (1.6)

13.5 (6.5)
11.4 (5.8)

10.5 (6.0)
11.8 (6.4)

11.4 (5.3)
10.4 (5.0)

20.9 (9.3)
17.8 (5.7)

19.2 (7.8)
13.3 (5.6)*

25.8 (7.1)
9.7 (4.0)*

0.187
0.067

37.5 (34.4)
48.8 (32.5)*

50.0 (33.3)
30 (35.0)*

53.8 (27.0)
6.3 (19.8)*

0.497
0.013

0.57

38.9 (37.1)
27.8 (30.6)*

40.0 (35.2)
31.1 (33.9)

21.1 (24.3)
12.2 (17.7)*

0.364
0.297

0.31

60.0 (41.0)
49.9 (39.3)

67.5 (38.6)
43.4 (31.6)*

62.5 (25.8)
3.3 (10.5)*

0.893
0.003

0.88

57.5 (27.8)
56.3 (30.8)

60.0 (18.4)
45.0 (14.7)*

55.0 (18.8)
5.0 (8.7)*

0.880
<0.001

0.85

24.0 (33.7)
16.0 (26.3)

20.0 (32.6)
18.0 (30.5)

16.0 (18.4)
6.0 (9.7)

0.829
0.495

0.25

46.0 (32.7)
46.0 (37.8)

48.0 (39.1)
40.0 (36.5)

36.0 (33.7)
33.5 (29.1)

0.721
0.725

0.10

FIS
Basal
6th week

57.5 (32.4)
52.4 (33.1)

62.5 (30.5)
46.1 (28.3)*

107.3 (24.1)
19.7 (10.1)*

0.008
0.061

1.11

FSS
Basal
6th week

5.0 (1.6)
4.8 (1.6)

5.2 (1.8)
3.7 (1.6)*

5.5 (1.2)
1.9 (0.5)*

0.763
<0.001

1.05

UPDRS I
Basal
6th week
UPDRS II
Basal
6th week
UPDRS III
Basal
6th week

NHP pain
Basal
6th week
NHP emotional
Basal
6th week
NHP energy
Basal
6th week
NHP physical
Basal
6th week
NHP social isolation
Basal
6th week
NHP sleep
Basal
6th week

0.507
0.497

0.03

0.522
0.855

0.10

1.15

P1: P-value for basal measurements among the three groups.
P2: P-value for the measurements at the 6th week among the three groups.
*: P < 0.05 for pre- and posttraining measurements for each group.
6MWD: 6-min walk distance, BBS: Berg Balance Scale, UPDRS: Unified Parkinson’s Disease Rating Scale, NHP: Nottingham
Health Profile, FIS: Fatigue Impact Scale, FSS: Fatigue Severity Scale, m: meters, SD: standard deviation.
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disability in PD [24]. That study suggested that BWSTT
might be preferred in advanced PD patients with severe
postural instability, impaired balance, or orthostatic
hypotension that would limit conventional TT.
Only one study investigated the effect of BWSTT on
balance in PD. Balance improved only in the BWSTT
group (20% support) compared to either conventional
ground gait training or the nonexercised control group.
None of the groups were trained with balance exercises
[7]. Contrary to that study, a conventional rehabilitation
program including balance training was administered to
each group in our study with the concern of ethical issues.
This might explain the increase in BBS scores in all the
groups after training, which was different from the study
of Ganesan et al. However, the greatest improvement was
observed in the 20% BWSTT group in our study, indicating
the additional effect of BWSTT on balance performance.
Regarding the quality of life, none of the previous
studies investigated the effect of BWSTT in PD. In our
study, we observed that only the supported BWSTT (10%
and 20%) groups, not the unsupported TT group, showed
improvements in energy and physical subscores of NHP
after training. Interestingly, the pain subscore of NHP
increased significantly in the unsupported TT group
while it decreased in both supported groups. We suggest
that BWSTT might protect the joints by decreasing their
loading and thus provide movement with less pain. This
may be important in PD as subjects with moderate to
advanced disease have higher rates of pain, which may be
related to concomitant osteoarthritis [25,26]. Supporting
our findings, in a previous study of knee osteoarthritis
[27], pain reduction was achieved after 12 weeks of lower
body positive pressure supported TT compared with full
body weight TT.
Fatigue was found as the nonmotor symptom most
strongly associated with the level of physical activity in
PD [28]. Implementing physical activity, especially aerobic
training, is shown to be highly effective to reduce fatigue in
patients with other various medical conditions, including
multiple sclerosis [29], systemic lupus erythematosus [30],
and cancer [31]. Similarly, higher levels of physical activity

are expected to have a beneficial effect on relieving fatigue
in PD. Fatigue is reported by nearly half of patients with
PD and a metaanalysis of only two studies showed no
significant effect of aerobic exercise on the management of
fatigue [32,33]. However, the effect of BWSTT on fatigue
has not been examined. To our knowledge, this is the
first study to investigate the effect of BWSTT on fatigue.
We found that 6 weeks of BWSTT significantly reduced
fatigue in PD compared with unsupported TT. We suggest
that BWSTT might enhance longer durations of aerobic
exercise by providing higher walking speed with lowered
risk of falls and decreased burdens on the cardiopulmonary
system [34] compared to full body weight walking. Higher
pain levels in the unsupported TT group might provide an
explanation for decreased tolerability of full body weight
aerobic exercise, which limits its capability to increase
the functional capacity and physical fitness of the patient
and hence reduce fatigue. BWSTT might have promising
results in the management of fatigue in people with PD.
Importantly, BWSTT was well tolerated and
participants reported few adverse events such as muscle
or joint pain. Contrary to our observations, Berra et al.
reported that four patients with chronic pain or anxiety
could not tolerate BWSTT [24]. Although participants
had moderate to advanced PD, adherence to the treatment
was high in all groups. A previous study showed the
effectiveness of an intensive inpatient rehabilitation with
improved motor functions and Hoehn and Yahr Stages in
advanced PD [35]. Inpatient stay during the rehabilitation
program might play a role in achieving high rates of
participation.
As a limitation of this study, the follow-up period was
short for understanding the maintenance of the training
effects. Further studies are necessary to determine the
long-term effects of BWSTT in subjects with PD.
In conclusion, a 6-week BWSTT program with 10% or
20% support improved walking distance, balance, UPDRS
motor score, quality of life, and fatigue compared with
unsupported TT in subjects with PD. The 20% BWSTT
provided superior results in improving balance and fatigue.
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